Literature DB >> 2411449

Two-dimensional gel electrophoresis of cerebrospinal fluid proteins from patients with various neurological diseases.

F Wiederkehr, A Ogilvie, D J Vonderschmitt.   

Abstract

We subjected cerebrospinal fluid (CSF) samples from over 200 patients with various neurological diseases to two-dimensional electrophoresis. The series included non-inflammatory diseases such as epilepsy, amyotrophic lateral sclerosis, and polyneuropathy; and inflammatory diseases such as multiple sclerosis and neurolues. In the resulting electrophoretograms we considered mainly the region of CSF-specific proteins and the area corresponding to the immunoglobulin light chains. The former, at Mr 35 000-38 000, shows some interesting variations from one CSF to another. Samples from patients with various brain tumors show a specific change. A zone of oligoclonal immunoglobulin light chains appeared in all CSF samples with above-normal gamma-globulin content. These oligoclonal patterns remained constant and characteristic during the course of different diseases for several patients so examined. As expected, differences appeared in the patterns of immunoglobulin light chains from one individual to another, even among a group of patients with the same disease. The extent of the correlation of certain basic patterns with certain diseases cannot yet be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411449

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Improved mass spectrometry compatibility is afforded by ammoniacal silver staining.

Authors:  Mireille Chevallet; Hélène Diemer; Sylvie Luche; Alain van Dorsselaer; Thierry Rabilloud; Emmanuelle Leize-Wagner
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

2.  A map of cochlear perilymph protein based on high-resolution two-dimensional electrophoresis.

Authors:  E Arrer; G Oberascher; H J Gibitz
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

Review 3.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

4.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.